CIK: 0001802528 · Show all filings
Period: Q4 2019 (Next →)
Filing Date: Feb 12, 2020
Total Value ($000): $164,989 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ZOGENIX INC | 466,875 | $24,338 | 14.8% | $52.13 | — | COM NEW | 98978L204 |
| INSM | INSMED INC | 988,999 | $23,617 | 14.3% | $20.34 | 0.0% | COM PAR $.01 | 457669307 |
| ACAD | ACADIA PHARMACEUTICALS INC | 515,788 | $22,065 | 13.4% | $43.50 | 0.0% | COM | 004225108 |
| — | AMARIN CORP PLC | 841,714 | $18,046 | 10.9% | $21.44 | — | SPONS ADR NEW | 023111206 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 453,890 | $12,564 | 7.6% | $22.75 | 0.0% | COM | 462260100 |
| ARGX | ARGENX SE | 78,138 | $12,543 | 7.6% | $160.52 | — | SPONSORED ADR | 04016X101 |
| — | ALLAKOS INC | 128,662 | $12,269 | 7.4% | $95.36 | — | COM | 01671P100 |
| ENTA | ENANTA PHARMACEUTICALS INC | 161,949 | $10,005 | 6.1% | $61.99 | 0.0% | COM | 29251M106 |
| — | NEOLEUKIN THERAPEUTICS INC | 810,073 | $9,980 | 6.0% | $12.32 | — | COM | 64049K104 |
| — | KARYOPHARM THERAPEUTICS INC | 401,609 | $7,699 | 4.7% | $19.17 | — | COM | 48576U106 |
| ASND | ASCENDIS PHARMA A S | 29,676 | $4,129 | 2.5% | $139.14 | — | SPONSORED ADR | 04351P101 |
| — | ACHILLION PHARMACEUTICALS IN | 624,956 | $3,768 | 2.3% | $6.03 | — | COM | 00448Q201 |
| — | INTERSECT ENT INC | 80,238 | $1,998 | 1.2% | $24.90 | — | COM | 46071F103 |
| — | KINIKSA PHARMACEUTICALS LTD | 165,318 | $1,828 | 1.1% | $11.06 | — | COM CL A | G5269C101 |
| — | PROTEON THERAPEUTICS INC | 341,743 | $140 | 0.1% | $0.41 | — | COM | 74371L109 |